Lindemann et al. reported that COTI-2 decreased clonogenic survival of HNSCC cells and potentiated response to cisplatin and/or radiation in vitro and in vivo through p53-dependent and p53-independent mechanisms [6]. Here, TP53 is linked to head and neck squamous cell carcinoma.